Synaptogenix, Inc. (NASDAQ:SNPX) Sees Significant Decline in Short Interest

Synaptogenix, Inc. (NASDAQ:SNPX – Get Rating) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 2,300 shares, a decline of 94.1% from the April 30th total of 39,000 shares. Approximately 0.0% of the shares of the company are short sold. […]

Related Keywords

,Prelude Capital Management ,Renaissance Technologies ,Synaptogenix Company Profile ,Vanguard Group Inc ,Platform Technology Partners ,Nasdaq ,Synaptogenix Inc ,Get Rating ,Stock Down ,Technology Partners ,Capital Management ,Vanguard Group ,Synaptogenix Daily ,Synaptogenix ,Nasdaq Snpx ,Snpx ,Medical ,Stocks ,Options ,Put ,Call ,